Immediate-early protein of equid herpesvirus type 1 as a target for cytotoxic T-lymphocytes in the Thoroughbred horse

被引:3
作者
Kydd, Julia H. [1 ]
Case, Ruth [1 ]
Minke, Julius [2 ]
Audonnet, Jean-Christophe [2 ]
Wagner, Bettina [3 ]
Antczak, Douglas F. [4 ]
机构
[1] Anim Hlth Trust, Newmarket CB8 7UU, Suffolk, England
[2] Merial SAS, R&D, Lyon, France
[3] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, New York, NY 14853 USA
[4] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, New York, NY 14853 USA
关键词
VARICELLA-ZOSTER-VIRUS; CLASS-I EXPRESSION; JOINT REPORT; IDENTIFICATION; RESPONSES; CYTOMEGALOVIRUS; RECOGNITION; EPITOPES; ANTIGEN; EHV-1;
D O I
10.1099/vir.0.065888-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cytotoxic T-lymphocytes (CTLs) are associated with protective immunity against disease caused by equid herpesvirus type 1 (EHV-1). However, the EHV-1 target proteins for CTLs are poorly defined. This limits the development of vaccine candidates designed to stimulate strong CTL immunity. Here, classical CTL assays using lymphocytes from horses of three defined MHC class 1 types that experienced natural infection with EHV-1 and a modified vaccinia virus construct containing an EHV-1 gene encoding the immediate-early (IE) protein are reported. Horses homozygous for the equine leukocyte antigen (ELA)-A2 haplotype, but not the ELA-A5 haplotype, produced MHC-restricted CTL responses against the IE protein. Previously, horses homozygous for the ELA-A3 haplotype also mounted CTL responses against the IE protein. Both haplotypes are common in major horse breeds, including the Thoroughbred. Thus, the IE protein is an attractive candidate molecule for future studies of T-cell immunity to EHV-1 in the horse.
引用
收藏
页码:1783 / 1789
页数:7
相关论文
共 35 条
[1]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSES IN HORSES INFECTED WITH EQUINE HERPESVIRUS-1 [J].
ALLEN, G ;
YEARGAN, M ;
COSTA, LRR ;
CROSS, R .
JOURNAL OF VIROLOGY, 1995, 69 (01) :606-612
[2]   Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses [J].
Allen, George P. .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2008, 69 (12) :1595-1600
[3]  
ANTCZAK DF, 1986, ANIM GENET, V17, P363
[4]  
ARVIN AM, 1991, J IMMUNOL, V146, P257
[5]  
BERGEN R E, 1991, Viral Immunology, V4, P151, DOI 10.1089/vim.1991.4.151
[6]   Novel classical MHC class I alleles identified in horses by sequencing clones of reverse transcription-PCR products [J].
Chung, C ;
Leib, SR ;
Fraser, DG ;
Ellis, SA ;
McGuire, TC .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 2003, 30 (06) :387-396
[7]   Control of EHV-1 viremia and nasal shedding by commercial vaccines [J].
Goehring, L. S. ;
Wagner, B. ;
Bigbie, R. ;
Hussey, S. B. ;
Rao, S. ;
Morley, P. S. ;
Lunn, D. P. .
VACCINE, 2010, 28 (32) :5203-5211
[8]   Herpesviruses and immunity: The art of evasion [J].
Griffin, Bryan D. ;
Verweij, Marieke C. ;
Wiertz, Emmanuel J. H. J. .
VETERINARY MICROBIOLOGY, 2010, 143 (01) :89-100
[9]   An ordered BAC contig map of the equine major histocompatibility complex [J].
Gustafson, AL ;
Tallmadge, RL ;
Ramlachan, N ;
Miller, D ;
Bird, H ;
Antczak, DF ;
Raudsepp, T ;
Chowdhary, BP ;
Skow, LC .
CYTOGENETIC AND GENOME RESEARCH, 2003, 102 (1-4) :189-195
[10]   RESPONSES OF PONIES TO EQUID HERPESVIRUS-1 ISCOM VACCINATION AND CHALLENGE WITH VIRUS OF THE HOMOLOGOUS STRAIN [J].
HANNANT, D ;
JESSETT, DM ;
ONEILL, T ;
DOLBY, CA ;
COOK, RF ;
MUMFORD, JA .
RESEARCH IN VETERINARY SCIENCE, 1993, 54 (03) :299-305